The Latest Breaking News from FDA

The healthcare industry is set to grow significantly due to technological advances, an aging population, and increasing demand for quality healthcare. To that end, it could be wise to buy fundamentally strong healthcare stocks like Abbott Laboratories (ABT), Stryker (SYK), and Centene (CNC), which are set to benefit from these…

FDA revoked the authorization for the use of brominated vegetable oil, a common food additive used in sports drinks and sodas, citing safety concerns.

The FDA will no longer allow BVO in food due to safety concerns revealed in studies.

The 5th Circuit ruled that the agency violated the Administrative Procedure Act when it rejected applications from manufacturers of flavored nicotine e-liquids.

Experts say the DEA’s rescheduling of cannabis as a medication will be ‘a little bit incoherent’

The justices find that a president has immunity for ‘official acts’ but is not immune for ‘unofficial acts’ — and refer the matter back to a trial judge

Kisunla manufactured by Eli Lilly could significantly slow cognitive decline in people with early symptomatic Alzheimer's disease, according to results of the company's clinical trials.

FDA recalls potassium chloride capsules from Glenmark Pharmaceuticals and American Health Packaging due to failed dissolution, posing heart attack risks.

FDA approves Eli Lilly's donanemab for early Alzheimer's, offering hope for patients and caregivers. Treatment priced at 5 per vial.

Salmonella can cause symptoms that begin six hours to six days after ingesting the bacteria

At least 48 people in 24 states said they got sick after eating Diamond Shruumz-brand products